GlassScriptPhysician profile
Allison Kendall
NPI 1134892730
$2,498.88
in general payments reported to CMS, 2019-2025
14 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $240 · 2022: $1,200 · 2023: $436 · 2024: $309 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $887.06 | 2022-2025 | Corevalve Evolut R |
| Impulse Dynamics (USA) INC. | $554.31 | 2022-2023 | Optimizer |
| Amgen INC. | $235.32 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $207.82 | 2021-2022 | |
| Abiomed | $156.91 | 2022-2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $133.21 | 2025 | |
| Cvrx, INC. | $123.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $49.46 | 2022 | |
| Boston Scientific Corporation | $43.66 | 2022-2025 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $29.85 | 2022 | |
| Cardiva Medical, INC. | $23.61 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Sumitomo Pharma America, INC. | $20.02 | 2024 | Gemtesa |
| United Therapeutics Corporation | $17.59 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Kendall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.